ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "morbidity and mortality"

  • Abstract Number: 2582 • 2015 ACR/ARHP Annual Meeting

    Increased Morbidity and Mortality in Female Versus Male Tumor Necrosis Factor-Transgenic Mice

    Richard Bell1, Ronald Wood2, Joe Chakkalakal3, Christopher T. Ritchlin4, Edward Schwarz5 and Homaira Rahimi6, 1Pathology, University of Rochester, Rochester, NY, 2University of Rochester, Rochester, NY, 3Orthopaedics, University of Rochester, Rochester, NY, 4Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, 5Orthopedeatrics, University of Rochester, Rochester, NY, 6Rheumatology, University of Rochester/Golisano Children's Hosp, Rochester, NY

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic debilitating condition with a 2-3 fold greater prevalence in women than men. Additionally, women have worse disease outcomes…
  • Abstract Number: 3240 • 2015 ACR/ARHP Annual Meeting

    Improved Survival in Rheumatoid Arthritis: A General Population-Based Study

    Na Lu1,2, Hyon K. Choi3, Sara R. Schoenfeld3, Christine Peloquin4, Maureen Dubreuil5, Sharan K. Rai6, J Antonio Avina-Zubieta7 and Yuqing Zhang8, 1Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2Boston University School of Medicine, Boston, MA, 3Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 4Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 5Rheumatology, Boston VA HealthCare System, Boston, MA, 6Experimental Medicine, University of British Columbia, Vancouver, BC, Canada, 7Arthritis Research Canada / University of British Columbia, Vancouver, BC, Canada, 8BUSM, Boston, MA

    Background/Purpose: All-cause mortality in UK has been decline by almost 20% over the past two decades. While rheumatoid arthritis (RA) is associated with an increased…
  • Abstract Number: 41 • 2015 ACR/ARHP Annual Meeting

    Trends in Non-Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis: Is There Room for Improvement?

    Elena Myasoedova1, Cynthia S. Crowson2, Eric L. Matteson3, John M. Davis III4 and Sherine E. Gabriel5, 1Internal Medicine and Rheumatology, Mayo Clinic, Rochester, MN, 2Health Sciences Research, Mayo Clinic, Rochester, MN, 3Rheumatology, Mayo Clinic, Rochester, MN, 4Division of Rheumatology, Mayo Clinic, Rochester, MN, 5Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ

    Background/Purpose: Rheumatoid arthritis (RA) is associated with increased all-cause and cause-specific mortality, including mortality from cardiovascular (CV) disease, respiratory causes, infections and malignancy. Evidence of…
  • Abstract Number: 42 • 2015 ACR/ARHP Annual Meeting

    Does the Risk of Mortality in Patients with RA Change over Time or Disease Duration?

    Kaleb Michaud1,2, Sofia Pedro2, Bryant R. England3 and Frederick Wolfe2, 1Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 2National Data Bank for Rheumatic Diseases, Wichita, KS, 3Division of Rheumatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Observational studies have shown an increased risk of mortality in patients with RA, though none have done so with patients from all 50 US…
  • Abstract Number: 223 • 2015 ACR/ARHP Annual Meeting

    Increased Platelet Reactivity in Gout: A Potential Mechanism for Adverse Cardiovascular Events

    Richard Conway1, Claire-Louise Murphy2, Anne Madigan2, Patricia Kavanagh2, Liz Geraghty2, Laura Helbert2, Kelly Stephens3, John J. Carey4, Eimear Dunne5, Dermot Kenny5 and Geraldine M. McCarthy6, 1Rheumatology, Mater Misericordiae University Hospital, Dublin 2, Ireland, 2Rheumatology, Mater Misericordiae University Hospital, Dublin 7, Ireland, 3Mater Misericordiae University Hospital, Clinical Research Center, Dublin, Ireland, 4Rheumatology, Galway University Hospitals, Galway, Ireland, 5Molecular and Cellular Therapeutics, RCSI, Dublin 2, Ireland, 6University College Dublin, Dublin, Ireland

    Background/Purpose: Patients with inflammatory arthritis, including gout, have an increased risk of cardiovascular events and mortality. Increased platelet reactivity is a risk marker for cardiovascular…
  • Abstract Number: 826 • 2015 ACR/ARHP Annual Meeting

    Systemic Sclerosis Inpatient Mortality Has Not Improved from 1995-2011. Results from a National Irish Audit of Scleroderma Co-Morbidities.

    Len Harty1, Deirdre Fitzgerald2, Michael Henry2, John Ryan3 and Sinead Harney3, 1Cork University Hospital, Cork, Ireland, 2Respiratory, Cork University Hospital, Cork, Ireland, 3Rheumatology, Cork University Hospital, Cork, Ireland

    Background/Purpose: Despite the advent of potent immunosuppressive and vasoactive therapies it is not clear that longevity of patients with systemic sclerosis (SSc) has improved. Therefore…
  • Abstract Number: 877 • 2015 ACR/ARHP Annual Meeting

    Improved Survival in Granulomatosis with Polyangiitis: A Population-Based Study

    Ju Ann1, Hyon K. Choi2, Sharan K. Rai3, Eric C. Sayre4 and J Antonio Avina-Zubieta5,6, 1Experimental Mediine, University of British Columbia, Richmond, BC, Canada, 2Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 3Experimental Medicine, University of British Columbia, Vancouver, BC, Canada, 4Arthritis Research Canada, Richmond, BC, Canada, 5Arthritis Research Canada / University of British Columbia, Vancouver, BC, Canada, 6Medicine, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada

    Background/Purpose: Granulomatosis with Polyangiitis (GPA) is associated with an increased risk of mortality. However, recent mortality trends in GPA are largely unknown, particularly in the…
  • Abstract Number: 2941 • 2014 ACR/ARHP Annual Meeting

    Physical Function Is Independently Associated with Mortality Among Individuals with Knee and/or Hip OA: The Johnston County Osteoarthritis Project

    Rebecca J. Cleveland1, Todd Schwartz1, Jordan B. Renner2, Joanne M. Jordan3 and Leigh F. Callahan4, 1Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2University of North Carolina Department of Radiology, Chapel Hill, NC, 3University of North Carolina Dept of Epidemiology, Chapel Hill, NC, 4Thurston Arthritis Res Ctr, University of North Carolina, Chapel Hill, NC

    Background/Purpose Declining physical function (PF) is a common consequence of osteoarthritis (OA), and poor PF is associated with death. It is possible that the resulting…
  • Abstract Number: 2620 • 2014 ACR/ARHP Annual Meeting

    Mortality and Survival in Systemic Lupus Erythematosus Patients: Trends in a Spanish Cohort from 1985 to 2013

    Sergi Heredia1, Javier Narváez2, Andrea Zacarias1, Milagros Ricse1, Gloria Albert1, Eulalia Armengol1, Helena Borrell1, Olga Capdevila3, Francesca Mitjavila3, Toni Rozadilla1, Xavier Juanola4 and Joan Miquel Nolla1, 1Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 2Rheumatology, Hospital Universitario de Bellvitge. Barcelona. Spain, Barcelona, Spain, 3Internal Medicine, Hospital Universitario de Bellvitge, Barcelona, Spain, 4Rheumatology, University Hospital Bellvitge, Barcelona, Spain

    Background/Purpose: To study the mortality, survival and causes of death in a Spanish cohort of patients with systemic lupus erythematosus (SLE) over a 28-year period…
  • Abstract Number: 2188 • 2014 ACR/ARHP Annual Meeting

    Incidence and Mortality of Relapsing Polychondritis in the United Kingdom: A Population-Based Cohort Study

    Nisha Hazra1, Alex Dregan1, Judith Charlton1, Martin C Gulliford1 and David P. D'Cruz2, 1Division of Primary Care and Public Health Research, King's College London, London, United Kingdom, 2Louise Coote Lupus Unit, Guy's and St Thomas' Hospital, London, United Kingdom

    Background/Purpose: To estimate the incidence, prevalence and mortality of Relapsing Polychondritis (RP), and to describe the clinical features of RP, in a large population.  Methods:…
  • Abstract Number: 2038 • 2014 ACR/ARHP Annual Meeting

    Respiratory Cause Mortality Was Significantly Predicted By Incident Rheumatoid Arthritis (RA) and Higher Pre-RA Levels (0.50+ SD) of Soluble Interleukin-2 Receptor Alpha (sIL-2Rá): Results of a 21-Year Community-Based Cohort Survival Analysis

    Alfonse T. Masi1, Azeem Rehman1, Huaping Wang1 and Jean Aldag2, 1Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, 2Medicine, University of Illinois College of Medicince at Peoria, retired, Peoria, IL

    Background/Purpose: Interstitial lung disease (ILD) mortality is reported to be increased in RA (Bongartz T et al. A&R 2010; 62: 1583-91). However, non-malignant respiratory mortality…
  • Abstract Number: 1829 • 2014 ACR/ARHP Annual Meeting

    Role of Fluorinated Steroids in Preventing the Progression of Anti-SSA/Ro Associated Isolated Congenital Heart Block to Disease Beyond the Conduction System

    Ummara Shah1, Amit Saxena1, Sara Sahl2, Deborah Friedman3, Jill P. Buyon1 and Peter M. Izmirly2, 1Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 2Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 3Division of Pediatric Cardiology, New York Medical College, Valhalla, NY

    Background/Purpose: The cardiac manifestations of neonatal lupus (cardiac NL) characteristically present as conduction disease.  A major concern is the extension of injury beyond the AV…
  • Abstract Number: 1803 • 2014 ACR/ARHP Annual Meeting

    Knee Osteoarthritis and All-Cause Mortality: The Wuchuan Osteoarthritis Study

    Qiang Liu1, Xu Tang Sr.2, Jingbo Niu3, Xu Wu4, Yan Ke5, Jian Huang6, Rujun Li5, Hu Li5, Xin Zhi5, Kai Wang5, Zhengming Cao1 and Jianhao Lin2, 1Arthritis Institute, People’s Hospital, Peking University, Beijing, China, 2Peking University Health Science Center, Beijing, China, 3Clinical Epidemiology Research and Training Unit, Boston University, Boston, MA, 4Peking University People's Hospital Arthritis Clinic & Research Center, Peking University Health Science Center, Beijing, China, 5Peking University People’s Hospital, Beijing, China, 6Orthopeadics, The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China

    Background/Purpose Several studies published recently found that knee osteoarthritis (OA) is associated with an increased mortality in Caucasians. While prevalence of knee OA is higher…
  • Abstract Number: 1431 • 2014 ACR/ARHP Annual Meeting

    Influence of Radiographic Joint Damage in Mortality Risk in a Cohort of Rheumatoid Arthritis Patients: A 20 Years Survival Study

    L. Rodriguez-Rodriguez1,2, J. Ivorra-Cortes3, Lydia Abasolo1,4, Leticia Leon1,4, Oscar Fontsere5, B. Fernández-Gutiérrez1,5 and Juan A Jover1,4, 1Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain, 2Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, 3Rheumatology, University Hospital la Fe, Valencia, Spain, 4Rheumatology, Hospital Clinico San Carlos, Madrid, Spain, 5Rheumatology, Hospital Clínico San Carlos, Madrid, Spain

    Background/Purpose Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increased mortality and reduced life expectancy compared with the general population. This mortality gap…
  • Abstract Number: 1391 • 2014 ACR/ARHP Annual Meeting

    Weight Loss and Risk of Death in Rheumatoid Arthritis

    Joshua Baker1, Erica Billig2, Grant W. Cannon3, Liron Caplan4, Vikas Majithia5 and Ted R. Mikuls6, 1Medicine/Rheumatology, University of Pennsylvania, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA, 3Division of Rheumatology, Salt Lake City VA and University of Utah, Salt Lake City, UT, 4Div of Rheumatology, Denver VA and Univ of Colorado School of Medicine, Aurora, CO, 5Div of Rheumatology, University of Mississippi Medical Center, Jackson, MS, 6Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE

    Background/Purpose Low body mass index (BMI) has been linked to greater mortality among patients with Rheumatoid Arthritis (RA). Weight loss has also been associated with…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology